Snake venom phospholipases A2: A new class of antitumor agents

Protein and Peptide Letters

Volumn 16, Issue 8, 2009, Pages 894-898

  Rodrigues, Renata S ^a   Izidoro, Luiz Fernando M ^a   De Oliveira, Robson J ^a   Sampaio, Suely V ^b   Soares, Andreimar M ^b   Rodrigues, Veridiana M ^a  

^a FEDERAL UNIVERSITY OF UBERLÂNDIA   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Antitumor effect; Phospholipase A2; Snake venom; VRCTC 310

Indexed keywords

ANTINEOPLASTIC AGENT; PHOSPHOLIPASE A2; SNAKE VENOM;

ANIMAL; ARTICLE; ENZYMOLOGY; HUMAN; METABOLISM; NEOPLASM; SNAKE;

ANIMALS; ANTINEOPLASTIC AGENTS; HUMANS; NEOPLASMS; PHOSPHOLIPASES A2; SNAKE VENOMS; SNAKES;

VIPERIDAE;

EID: 68849089261     PISSN: 09298665     EISSN: None     Source Type: Journal    
DOI: 10.2174/092986609788923266     Document Type: Article

References (45)

1. 2-a structural review. Toxicon, 1996, 34(8), 827-841.
2. 2 enzymes. Toxicon, 2003, 42(8), 827-840.
3. 2 and their receptors and binding proteins. Biochim. Biophys. Acta, 2000, 1488(6), 59-70. (Pubitemid 30842580)
4. 2 as targets for anti-cancer drugs. Biochem. Pharmacol., 2007, 74(7), 949-959.
5. 2. Cell Development. Biol., 1997, 8(3), 297-303.
6. Homsi-Brandeburgo, M. I.; Queiroz, L. S.; Santo-Neto, H.; Rodrigues-Simioni, L.; Giglio, J. R. Fractionation of Bothrops jararacussu snake venom: partial chemical characterization and biological activity of bothropstoxin. Toxicon, 988, 26(7), 615-627.
7. 2s. Toxicon, 2003, 42(8), 903-913.
8. 2 from Agkistrodon piscivorus piscivorus venom. Eur. J. Biochem., 1988, 176(5), 353-357.
9. 2+ - independent membrane-damaging activity and increases its toxicity. Biochemistry, 2007, 46(6), 12795-1280. (Pubitemid 350060101)
10. 2 from Vipera ammodytes venom. Toxicon, 1982, 20(6), 1051-1058. (Pubitemid 13189881)
11. 2 from the long-nosed viper (Vipera ammodytes ammodytes) venom. Eur. J. Biochem, 1992, 204(2), 1057-1062.
12. 2, ecarpholin S, from the venom of Echis carinatus sochureki (saw-scaled viper), Biochem. J, 1996, 319(3), 961-968. (Pubitemid 126732890)
13. 2 in Swiss 3T3 cells via specific binding site. J. Biol. Chem, 1991, 266(7), 19139-19141. (Pubitemid 21908205)
14. 2: mediators of inflammation, proliferation and apoptosis. Prog. Lipid Res., 2001, 40(3), 167-197.
15. Ding, X. Z.; Hennig, R.; Adrian, T. E. Lipoxygenase and cyclooxygenase metabolism: New insights in treatment and chemoprevention of pancreatic cancer. Mol. Cancer, 2003, 2(4), 10-14. (Pubitemid 38751487)
16. Breyer, R. M.; Kennedy, C. R. J.; Zhang, Y.; Breyer, M. D. Structurefunction analyses of eicosanoid receptors. Physiologic and therapeutic implications. Ann. N. Y. Acad. Sci., 2000, 905(5), 221-231.
17. Leyton, J.; Manyak, M. J.; Mukherjee, A. B.; Miele, L. Mantile G. I. L. Patierno S. Recombinant human uteroglobin inhibits the in vitro invasiveness of human metastatic prostate tumor cells and the release of arachidonic acid stimulated by fibroblast-conditioned medium. Cancer Res., 1994, 54(7), 3696-3699. (Pubitemid 24241181)
18. 2 in prostate cancer. Cancer Lett., 2006, 240(8), 9-16. (Pubitemid 44037166)
19. Calmette, A.; Saenz, A.; Costil, L. Effects du venin de cobra sur les greffes cancereuses et surle cancer spontane (adeno-carcinome) de la souris. Acad. Sci, 1933, 197(8), 205-217.
20. Cotte, C. A.; Essenfeld-Yahir, E.; Lairet, C. Effects of Crotalus and Bothrops venom on normal and malignant cells cultivated in vitro. Toxicon, 1972, 10(2), 157-161.
21. Braganca, B. M. Biologically active components of cobra venom in relation to cancer research. Indian J. Med. Res., 1976, 64(3), 1197-1207
22. Chaim-Matyas, A.; Ovadia, M. Cytotoxic activity of various snake venoms on melanoma, B16F10 and chondrosarcoma. Life Sci., 1987, 40(16), 1601-1607. (Pubitemid 17046057)
23. Balbani, A. P.; Avakian, A.; Waitzberg, D. L. Tumor necrosis factor: Biology, immunology, and systemic impact. Rev. Assoc. Med. Bras., 1993, 39(4), 115-121.
24. Pereira-Bittencourt, M.; Carvalho, D. D.; Gagliardi, A. R.; Collins, D. C. The effect of a lectin from the venom of the snake, Bothrops jararacussu, on tumor cell proliferation. Anticancer Res., 1999, 19(10), 4023-4025.
25. de Carvalho, D. D.; Schmitmeier, S.; Novello, J. C.; Markland F., S.; Effect of BJcuL (a lectin from the venom of the snake Bothrops jararacussu) on adhesion and growth of tumor and endothelial cells. Toxicon, 2001, 39(10), 1471-1476. (Pubitemid 32722033)
26. da Silva, R. J.; da Silva, M. G.; Vilela, L. C.; Fecchio, D. Cytokine profile of Ehrlich ascites tumor treated with Bothrops jararaca venom. Mediators Inflamm., 2002, 11(3), 197-201. (Pubitemid 35155461)
27. 2 homologues of snake venoms. Cell Biol. Int., 2007, 31(3), 263-268. (Pubitemid 46275481)
28. 2 homologue from Bothrops asper snake venom induces proliferation, apoptosis and necrosis in a lymphoblastoid cell line. Toxicon, 2005, 45(5), 651-660. (Pubitemid 40381025)
29. Lipps, B. V. Selective cytolitic activity of snake venom proteins, atroporin and kaotree on various types of cancer cells. World Congress on Animal, Plant Microbial. Toxins, 1994, 11(3), 11-12.
30. Markland, F. S. Antitumor action of crotalase, a defibrinogenating snake venom enzyme. Semin Thromb. Hemost., 1986, 12(1), 284-290.
31. Lomonte, B.; Tarkowski, A.; Hanson, L. A. Host response to Bothrops asper snake venom. Analysis of edema formation, inflammatory cells, and cytokine release in a mouse model. Inflammation, 1993, 179(8), 93-105. (Pubitemid 23105184)
32. Barraviera, B.; Lomonte, B.; Tarkowski, A.; Hanson, L. A.; Meira, D. A. Acute-phase reactions, including cytokines, in patients bitten by Bothrops and Crotalus snakes in Brazil. J. Venom Anim. Toxins, 1995, 1(2), 11-22.
33. 2. Toxicon, 2005, 46(5), 523-532. (Pubitemid 41253370)
34. 2 homologue: An example of function versatility of snake venom proteins. Comp Biochem. Physiol. C. Toxicol. Pharmacol., 2006, 142(3-4), 371-381.
35. 2, on liposomes and mouse gastrocnemius muscle. Toxicon, 1993, 31(2), 217-222.
36. 2 from Indian cobra (Naja naja naja) venom. Toxicon, 1998, 36(6), 921-932.
37. Kang, I. C.; Kim, D. S.; Jang, Y.; Chung, K. H. Suppressive mechanism of salmosin, a novel disintegrin in B16 melanoma cell metastasis. Biochem. Biophys. Res. Commun, 2000, 275(9), 169-173. (Pubitemid 30663647)
38. Yamazaki, Y.; Tokunaga, Y.; Takani, K.; Morita, T. C-terminal heparin-binding peptide of snake venom VEGF specifically blocks VEGF-stimulated endothelial cell proliferation. Pathophysiol. Haemost. Thromb., 2005, 34(7), 197-199. (Pubitemid 43760353)
39. Papo, N.; Shahar, M.; Eisenbach, L.; Shai, Y. A novel lytic peptide composed of DL-amino acids selectively kills cancer cells in culture and in mice. J. Biol. Chem., 2003, 278(5), 1018-21023. (Pubitemid 36806412)
40. Newman, R. A.; Vidal, J. C. Viskatis, L. J. Johnson, J. Etcheverry M. A. VRCTC-310-a novel compound of purified animal toxins separates antitumor efficacy from neurotoxicity. Invest. New Drugs, 1993, 11(3), 151-159. (Pubitemid 23277235)
41. Hendon, R. A.; Fraenkel-Conrat, H. Biological roles of the two components of crotoxin. Proc. Natl. Acad. Sci. USA, 1971, 68(8), 1560-1563.
42. 2, NSC-624244) in patients with advanced cancer. Clin. Cancer Res., 2002, 8(8), 033-1041. (Pubitemid 35177352)
43. 2 toxin. A novel growth inhibitory mechanism. Biochem. Pharmacol., 1996, 51(11), 1535-1543. (Pubitemid 126333981)
44. 2 (crotoxin+cardiotoxin) on serum IL-1alpha, TNF-alpha and IL-1 level in humans. Immunol. Lett., 2001, 75(2), 137-141.
45. Costa, L. A.; Miles, H.; Araujo, C. E.; González, S.; Villarrubia, V. G. Tumor regression of advanced carcinomas following intraand/or peri-tumoral inoculation with VRCTC-310 in humans: Preliminary report of two cases. Immunopharmacol. Immunotoxicol., 1998, 20(6), 15-25. (Pubitemid 28157288)